Navigation Links
Lighting the Onco-Pipeline, Stem Cell Cancer, and More at Global Cancer Congress, January 28-29, 2008, Tampa
Date:9/18/2007

NEW YORK, Sept. 18 /PRNewswire/ -- iiBIG is pleased to announce the never- before assembly of Global Cancer Experts at the 2008 Global Cancer Congress: Lighting the Onco-Pipeline -- Innovations in Stem Cell, Biomarker, Chemistry & Novel Therapeutic R&D, January 28-29, 2008 in Tampa, Florida. iiBIG is particularly pleased to join forces with our Florida affiliates from University of South Florida, University of Florida, Shands Cancer Center, Scripps Florida, and the other Florida cancer and academic institutes along with our nationally recognized distinguished faculty at this cutting-edge event.

This event will be the torchbearer to the most significant advances in cancer research, new therapies and novel approaches in the "War against Cancer". The program features a 2-track forum, with over 30 speakers, comprising plenary keynotes, lectures, panel sessions, roundtable discussions, interactive conversations with faculty and delegates, and actionable networking opportunities with leaders in various aspects of cancer research.

Distinguished Executive Speaking Faculty:

David L. Keefe, M.D.

James M. Ingram Professor and Chairman of the Department of Obstetrics and

Gynecology

University of South Florida

George Church, Ph.D.

Director of the Center for Computational Genetics, Director of the

Department of Genetics

Harvard-MIT Division of Health Sciences & Technology and Harvard Medical

School, Harvard University

William G. Thilly, Sc.D.

Professor of Biological Engineering

MIT

David J. Newman, Phil Sc.,

Chief, Natural Products Branch

National Cancer Institute (NCI)-FCRDC

James L. Sherley, M.D., Ph.D.

Senior Scientist

Regenerative Biology and Cancer Programs

Boston Biomedical Research Institute

Edward Scott, Ph.D.

Director of the UF Program in Stem Cell Biology and Regenerative Medicine

University of Florida

Gary D. Smith, Ph.D.,

Associate Professor, Departments of OB/GYN, Physiology, and Urology

Director: Reproductive Sciences Program, University of Michigan

James D. McChesney, Ph.D.,

CSO, Natural Products Chemistry

Tapestry Pharmaceuticals, Inc.

Tomi Sawyer, Ph.D.,

Senior Director, Department of Chemical Sciences

Pfizer Global R&D

Michael Nickerson

Director Genomic Research Division

Transgenomic Labs

Dalia Cohen, Ph.D.

Executive Vice President, Head of Global Research and Development

Rosetta Genomics, Ltd.

Gregg B. Fields, Ph.D.,

Professor and Chair, Department of Chemistry & Biochemistry

Florida Atlantic University

Chris Liang, Ph.D.

Scientific Director I, Translational Research Institute

Scripps Florida

Marilyn A. Apfel, Ph.D.

Co-founder and President

xFDA, LLC

Julia H. Riley, DVM, MS,

Diplomate American College Veterinary Pathologists, Diplomate American

Board Toxicology, Heads the Biologics Division, Toxicologist

xFDA, LLC

Ahsan Awan, JD, MBA,

Chief Executive Officers

Global CINRG, Inc.

Bernard Munos, Ph.D.,

Advisor, Corporate Strategy

Eli Lilly and Company

Stephen Chakoff

President & CEO

CHS Resources LLC

Jean-Claude Bystryn, M.D.

CEO & CSO

NeoVac

Glenn Batchelder

President and CEO

BIND Biosciences, Inc., latest Robert Langer, Ph.D. - MIT, Nanotechnology

Company

Christopher Milne, D.V.M., M.P.H., J.D.

Associate Director

Tufts Center for Drug Development

Mark Newman, Ph.D.

Senior Vice President, Global Research and Development Laboratories

Pharmexa-Epimmune

AGENDA TOPICS:

Some of the conference topics to be addressed (but are not limited to) include:

-- Integrative BioPharma Oncogenomics Standardizing Genetic Analysis

-- Drug Discovery Breakthroughs-Promising Compounds

-- Stem Cell Biology & Genetic Integrity

-- Interplay between Cancer & Stem Cells

-- Immunology

-- Micro-Tumor-Environment

-- Proteomic Biomarkers - Molecular Diagnostics: Earlier Detection and

Customizing Care

-- Therapeutic Vaccines Advancements

-- Multi-Drug Interaction - Drug Safety

-- Cancer Susceptibility, Resistance, and Systemic Changes

-- New Drugs Showing Real Promise

-- C-Team - Business Collaboration & Alliances between academia,

government, industry, foundations, regulatory, and private investment

resources - The Real Scenarios!

-- Biotech Showcase: Visit with 5 exciting young biotechnology companies*

in the cancer marketplace - The Real Light Makers

SPEAKING OPPORTUNITIES: Topic abstracts and speaker profiles will be accepted for consideration.

For more information, please contact Shelley Amster, VP, Pharmaceutical & Life Sciences Conferences, iiBIG, at 978-371-5901 or Shelleya@iibig.com.

SPONSORSHIP OPPORTUNITIES: For information on available sponsorship and exhibiting opportunities, please contact Kellie Swanstrom, VP Business Development, iiBIG, at 973-571-0867 or kellies@iibig.com.

FOR CONFERENCE UPDATES AND REGISTRATION INFORMATION:

Please visit: http://www.iibig.com/P0801

Call: 212-300-2523

E-mail: info@iibig.com


'/>"/>
SOURCE iiBIG
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Cooper Lighting picks RedPrairie solutions
2. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
3. The state of global biotech: An Ernst & Young perspective
4. Doyle announces new energy, global warming policies
5. Lucigen Corp. enters global licensing agreement
6. Global information firm reaches diverse markets
7. Work-life imbalance - A global problem getting worse
8. Leading global Big Pharma companies of 2005
9. Learning to swim in the global talent pool
10. Federal and global guidelines on stem cell research offer a level playing field
11. Midwest life-science company Perrigo globalizes under the radar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... LEXINGTON, Massachusetts , February 4, 2016 - New ... --> - New FDA action date of July ... date of July 22, 2016   - ... the U.S. in the past decade indicated for the treatment of signs and ... Lifitegrast has the potential to be the only product approved in the ...
(Date:2/4/2016)... 4, 2016  CytoSorbents Corporation (NASDAQ: CTSO ... flagship CytoSorb® blood filter to treat deadly inflammation ... world, announced that CEO Dr. Phillip Chan ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... Conference Presentation Details: Where: Convene ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/3/2016)... 2016  Discovery Laboratories, Inc. (NASDAQ: DSCO ... KL4 surfactant therapies for respiratory diseases, today announced ... inducement award as a component of employment compensation ... President and Chief Executive Officer.  The award was ... 1, 2016 and granted as an inducement material ...
Breaking Biology Technology:
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... 2016  BioMEMS devices deployed in hospitals ... medical screening and diagnostic applications, such as ... that facilitate and assure continuous monitoring without ... being bolstered through new opportunities offered by ... coupled with wireless connectivity and low power ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 Technology Enhancements ... presents an analysis of the digital and computed radiography ... Malaysia , and Indonesia ... trends and market size, as well as regional market ... country and discusses market penetration and market attractiveness, both ...
Breaking Biology News(10 mins):